Verdad Advisers, LP
13F Reported Value
ⓘ$104.4M
Holdings
210
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Verdad Advisers, LP disclosed 210 positions worth $104.4M in its Form 13F-HR for Q2 2026, led by $AAPL (Apple Inc.) at 2.1% of the equity portfolio, followed by $BLTE and $ACAD. During the quarter the fund opened 97 new positions and exited 66 — including a new stake in $AAPL and a full exit from $STT. The portfolio is most concentrated in Healthcare (50.0% of disclosed assets). All figures are sourced directly from Verdad Advisers, LP’s Form 13F-HR filing with the SEC under CIK 1812822.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 76.4#84
Quality
$2.2M7,445 sh - —
Quality
$2.1M13,758 sh - 67.8#344
Quality
$2.1M82,629 sh - 59.5
Quality
$2.1M84,569 sh - 48.8
Quality
$1.9M140,000 sh - —
Quality
$1.8M123,174 sh - 78.1
Quality
$1.8M91,070 sh - 8.7
Quality
$1.7M66,688 sh - 54.5
Quality
$1.7M51,906 sh - 28.0
Quality
$1.6M352,093 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| 76.4#84 | $2.2M | 7,445 | |
| — | $2.1M | 13,758 | |
| 67.8#344 | $2.1M | 82,629 | |
| 59.5 | $2.1M | 84,569 | |
| 48.8 | $1.9M | 140,000 | |
| — | $1.8M | 123,174 | |
| 78.1 | $1.8M | 91,070 | |
| 8.7 | $1.7M | 66,688 | |
| 54.5 | $1.7M | 51,906 | |
| 28.0 | $1.6M | 352,093 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Verdad Advisers, LP's 210 positions.
Showing top 10 of 210 holdings.
Sector Allocation
Healthcare
$52.2M
Technology
$19.6M
Financials
$9.7M
Communication Services
$5.3M
Consumer Discretionary
$5.1M
Real Estate
$3.7M
Industrials
$3.0M
Materials
$2.7M
Top Holdings — Verdad Advisers, LP (Q2 2026)
Top 150 of 210 disclosed positions (by reported value) from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | Apple Inc. | $2.2M | 2.1% | NEW | 76.4 | |
| 2 | BELITE BIO, INC | $2.1M | 2.0% | -0% | — | |
| 3 | ACADIA PHARMACEUTICALS INC | $2.1M | 2.0% | +21% | 67.8 | |
| 4 | COMCAST CORP | $2.1M | 2.0% | +104% | 59.5 | |
| 5 | Chatham Lodging Trust | $1.9M | 1.8% | +0% | 48.8 | |
| 6 | TENAX THERAPEUTICS, INC. | $1.8M | 1.7% | +29% | — | |
| 7 | Slide Insurance Holdings, Inc. | $1.8M | 1.7% | +197% | 78.1 | |
| 8 | Zymeworks Inc. | $1.7M | 1.7% | -19% | 8.7 | |
| 9 | AMN HEALTHCARE SERVICES INC | $1.7M | 1.6% | +4% | 54.5 | |
| 10 | X4 Pharmaceuticals, Inc | $1.6M | 1.6% | NEW | 28 | |
| 11 | Versant Media Group, Inc. | $1.6M | 1.5% | +129% | 61 | |
| 12 | NETSCOUT SYSTEMS INC | $1.4M | 1.4% | +125% | 60.6 | |
| 13 | Whitehawk Therapeutics, Inc. | $1.4M | 1.3% | +161% | 26.4 | |
| 14 | JOHNSON & JOHNSON | $1.4M | 1.3% | -1% | 69 | |
| 15 | Contineum Therapeutics, Inc. | $1.3M | 1.3% | -6% | — | |
| 16 | Jade Biosciences, Inc. | $1.3M | 1.2% | NEW | — | |
| 17 | CISCO SYSTEMS, INC. | $1.2M | 1.2% | NEW | 70.3 | |
| 18 | Nurix Therapeutics, Inc. | $1.2M | 1.1% | -41% | 6.4 | |
| 19 | Protara Therapeutics, Inc. | $1.2M | 1.1% | NEW | — | |
| 20 | Bloomin' Brands, Inc. | $1.2M | 1.1% | +30% | 49.6 | |
| 21 | Tyra Biosciences, Inc. | $1.1M | 1.1% | NEW | — | |
| 22 | PAR PACIFIC HOLDINGS, INC. | $1.1M | 1.1% | -11% | 55.7 | |
| 23 | Edgewise Therapeutics, Inc. | $1.1M | 1.1% | +109% | — | |
| 24 | Alphabet Inc. | $1.0M | 1.0% | NEW | 78.2 | |
| 25 | CARTERS INC | $1.0M | 1.0% | +0% | 58.1 | |
| 26 | Vera Therapeutics, Inc. | $1.0M | 1.0% | +131% | — | |
| 27 | Nuvalent, Inc. | $1.0M | 1.0% | NEW | — | |
| 28 | Dianthus Therapeutics, Inc. /DE/ | $980,844 | 0.9% | +16% | 22.6 | |
| 29 | Aclaris Therapeutics, Inc. | $927,189 | 0.9% | -11% | 12 | |
| 30 | OPPENHEIMER HOLDINGS INC | $915,348 | 0.9% | +154% | 63.7 | |
| 31 | VERIZON COMMUNICATIONS INC | $886,515 | 0.8% | NEW | 65.8 | |
| 32 | MYERS INDUSTRIES INC | $865,095 | 0.8% | NEW | 54.1 | |
| 33 | Enliven Therapeutics, Inc. | $860,568 | 0.8% | NEW | — | |
| 34 | UNIVERSAL INSURANCE HOLDINGS, INC. | $850,279 | 0.8% | NEW | 62.8 | |
| 35 | Bank of New York Mellon Corp | $831,218 | 0.8% | -36% | 74.1 | |
| 36 | PC CONNECTION INC | $809,021 | 0.8% | NEW | 47.6 | |
| 37 | American Integrity Insurance Group, Inc. | $794,212 | 0.8% | +3% | 63.2 | |
| 38 | APPLIED MATERIALS INC /DE | $787,347 | 0.8% | -62% | 72.3 | |
| 39 | AdaptHealth Corp. | $781,500 | 0.8% | -21% | 42.3 | |
| 40 | ALLSTATE CORP | $780,205 | 0.8% | NEW | 78.5 | |
| 41 | Celldex Therapeutics, Inc. | $770,396 | 0.7% | NEW | 8.4 | |
| 42 | Revolution Medicines, Inc. | $759,046 | 0.7% | -81% | — | |
| 43 | Heritage Insurance Holdings, Inc. | $745,236 | 0.7% | +8% | 64.4 | |
| 44 | TD SYNNEX CORP | $743,205 | 0.7% | +92% | 58.4 | |
| 45 | MOVADO GROUP INC | $737,534 | 0.7% | +75% | 55.8 | |
| 46 | Smart Sand, Inc. | $714,847 | 0.7% | +16% | 56.5 | |
| 47 | Viridian Therapeutics, Inc.\DE | $711,323 | 0.7% | +24% | 27.2 | |
| 48 | Design Therapeutics, Inc. | $688,150 | 0.7% | -48% | — | |
| 49 | Marcus & Millichap, Inc. | $684,867 | 0.7% | +41% | 57.9 | |
| 50 | Mativ Holdings, Inc. | $681,300 | 0.7% | NEW | 52.8 | |
| 51 | StoneX Group Inc. | $673,317 | 0.6% | -18% | 68.9 | |
| 52 | CytomX Therapeutics, Inc. | $661,526 | 0.6% | +484% | 8.7 | |
| 53 | Net Lease Office Properties | $654,344 | 0.6% | +146% | 31.4 | |
| 54 | GERON CORP | $632,577 | 0.6% | NEW | — | |
| 55 | OOMA INC | $630,608 | 0.6% | +70% | 57.2 | |
| 56 | ROCKY BRANDS, INC. | $629,075 | 0.6% | +2% | 52.2 | |
| 57 | Janux Therapeutics, Inc. | $620,329 | 0.6% | NEW | 30.1 | |
| 58 | Zoom Communications, Inc. | $614,959 | 0.6% | -67% | 70.5 | |
| 59 | Structure Therapeutics Inc. | $608,349 | 0.6% | +0% | — | |
| 60 | Avalo Therapeutics, Inc. | $606,643 | 0.6% | NEW | 11.7 | |
| 61 | Mistras Group, Inc. | $603,169 | 0.6% | +0% | 47.6 | |
| 62 | VIEMED HEALTHCARE, INC. | $602,821 | 0.6% | NEW | 61.5 | |
| 63 | RELMADA THERAPEUTICS, INC. | $601,998 | 0.6% | +85% | — | |
| 64 | Climb Bio, Inc. | $601,340 | 0.6% | -68% | — | |
| 65 | Corbus Pharmaceuticals Holdings, Inc. | $596,596 | 0.6% | +27% | — | |
| 66 | BRISTOL MYERS SQUIBB CO | $591,354 | 0.6% | NEW | 70.4 | |
| 67 | SECURITY NATIONAL FINANCIAL CORP | $581,400 | 0.6% | +0% | 45.1 | |
| 68 | USANA HEALTH SCIENCES INC | $556,552 | 0.5% | +53% | 38.4 | |
| 69 | Talkspace, Inc. | $547,310 | 0.5% | -40% | 50.5 | |
| 70 | NVIDIA CORP | $547,246 | 0.5% | NEW | 85.9 | |
| 71 | UroGen Pharma Ltd. | $531,392 | 0.5% | NEW | — | |
| 72 | Atai Beckley N.V. | $530,589 | 0.5% | -56% | — | |
| 73 | California Resources Corp | $528,700 | 0.5% | -56% | 56.4 | |
| 74 | Cullinan Therapeutics, Inc. | $527,853 | 0.5% | +130% | — | |
| 75 | iBio, Inc. | $523,122 | 0.5% | +431% | 10.4 | |
| 76 | Viatris Inc | $516,100 | 0.5% | +0% | 45.4 | |
| 77 | InnovAge Holding Corp. | $499,347 | 0.5% | +33% | 55 | |
| 78 | Hello Group Inc. | $491,173 | 0.5% | -43% | — | |
| 79 | PMV Pharmaceuticals, Inc. | $485,564 | 0.5% | +101% | — | |
| 80 | NATIONAL HEALTHCARE CORP | $485,071 | 0.5% | NEW | 65.9 | |
| 81 | CIRRUS LOGIC, INC. | $484,950 | 0.5% | +1% | 66.8 | |
| 82 | MICRON TECHNOLOGY INC | $483,648 | 0.5% | -89% | 86.2 | |
| 83 | JONES LANG LASALLE INC | $481,042 | 0.5% | -51% | 64.2 | |
| 84 | APA Corp | $474,284 | 0.5% | NEW | — | |
| 85 | RMR GROUP INC. | $461,843 | 0.4% | NEW | 40.1 | |
| 86 | Fulcrum Therapeutics, Inc. | $458,320 | 0.4% | NEW | 32.9 | |
| 87 | PROG Holdings, Inc. | $437,295 | 0.4% | -58% | 57.4 | |
| 88 | Septerna, Inc. | $434,365 | 0.4% | NEW | 59.2 | |
| 89 | BioAge Labs, Inc. | $426,327 | 0.4% | +14% | 26.8 | |
| 90 | TERADYNE, INC | $424,812 | 0.4% | -56% | 77.3 | |
| 91 | ARROW ELECTRONICS, INC. | $421,698 | 0.4% | -15% | 55.7 | |
| 92 | INGLES MARKETS INC | $419,338 | 0.4% | NEW | 47.9 | |
| 93 | Erasca, Inc. | $411,467 | 0.4% | -32% | — | |
| 94 | Viant Technology Inc. | $403,601 | 0.4% | NEW | 61.9 | |
| 95 | QUALCOMM INC/DE | $399,331 | 0.4% | NEW | 70.5 | |
| 96 | Shattuck Labs, Inc. | $397,183 | 0.4% | +328% | — | |
| 97 | Zura Bio Ltd | $394,822 | 0.4% | -31% | — | |
| 98 | LAM RESEARCH CORP | $386,964 | 0.4% | -83% | 79.4 | |
| 99 | Savara Inc | $380,435 | 0.4% | -52% | — | |
| 100 | Maze Therapeutics, Inc. | $376,521 | 0.4% | NEW | 10.3 | |
| 101 | Sandisk Corp | $370,618 | 0.3% | NEW | 87.7 | |
| 102 | CORNING INC /NY | $368,330 | 0.3% | NEW | 73.7 | |
| 103 | WESTERN DIGITAL CORP | $365,987 | 0.3% | NEW | 80.7 | |
| 104 | NATURES SUNSHINE PRODUCTS INC | $359,613 | 0.3% | NEW | 51.2 | |
| 105 | KEWAUNEE SCIENTIFIC CORP /DE/ | $355,200 | 0.3% | NEW | 49.3 | |
| 106 | ALUMIS INC. | $342,942 | 0.3% | +33% | 7.1 | |
| 107 | AMKOR TECHNOLOGY, INC. | $340,522 | 0.3% | NEW | 57.5 | |
| 108 | vTv Therapeutics Inc. | $338,699 | 0.3% | NEW | — | |
| 109 | VILLAGE SUPER MARKET INC | $327,739 | 0.3% | NEW | 52.8 | |
| 110 | Kalaris Therapeutics, Inc. | $326,809 | 0.3% | NEW | — | |
| 111 | CITIGROUP INC | $322,048 | 0.3% | NEW | 65 | |
| 112 | PLIANT THERAPEUTICS, INC. | $320,731 | 0.3% | +186% | — | |
| 113 | Merck & Co., Inc. | $319,066 | 0.3% | -56% | 59.9 | |
| 114 | Harmony Biosciences Holdings, Inc. | $313,272 | 0.3% | NEW | 71.4 | |
| 115 | AMERICAN PUBLIC EDUCATION INC | $312,910 | 0.3% | -8% | 52.2 | |
| 116 | FORMFACTOR INC | $312,823 | 0.3% | -50% | 60 | |
| 117 | NOAH HOLDINGS LTD | $308,911 | 0.3% | +0% | — | |
| 118 | AT&T INC. | $307,436 | 0.3% | NEW | 65.7 | |
| 119 | DoubleDown Interactive Co., Ltd. | $306,573 | 0.3% | +86% | — | |
| 120 | Walmart Inc. | $306,255 | 0.3% | NEW | 60.2 | |
| 121 | Vistance Networks, Inc. | $304,241 | 0.3% | NEW | 33.8 | |
| 122 | Clear Secure, Inc. | $292,360 | 0.3% | NEW | 73.1 | |
| 123 | INTEST CORP | $280,745 | 0.3% | NEW | 26.2 | |
| 124 | KVH INDUSTRIES INC \DE\ | $273,437 | 0.3% | NEW | 32.1 | |
| 125 | TERADATA CORP /DE/ | $272,072 | 0.3% | NEW | 63.6 | |
| 126 | TACTILE SYSTEMS TECHNOLOGY INC | $271,445 | 0.3% | +17% | 56.1 | |
| 127 | BREAD FINANCIAL HOLDINGS, INC. | $271,200 | 0.3% | NEW | 52.5 | |
| 128 | Ingram Micro Holding Corp | $260,558 | 0.3% | NEW | 52.3 | |
| 129 | Foghorn Therapeutics Inc. | $259,767 | 0.3% | +118% | 16.1 | |
| 130 | LINCOLN EDUCATIONAL SERVICES CORP | $259,480 | 0.3% | -3% | 60.3 | |
| 131 | FinVolution Group | $257,218 | 0.3% | +255% | — | |
| 132 | MBX Biosciences, Inc. | $252,485 | 0.2% | NEW | — | |
| 133 | PERDOCEO EDUCATION Corp | $249,504 | 0.2% | -13% | 63.6 | |
| 134 | BK Technologies Corp | $241,948 | 0.2% | +3% | 69 | |
| 135 | FEDERATED HERMES, INC. | $240,483 | 0.2% | -68% | 67.5 | |
| 136 | ANAPTYSBIO, INC | $236,115 | 0.2% | NEW | 48.4 | |
| 137 | TScan Therapeutics, Inc. | $228,127 | 0.2% | +74% | 13.9 | |
| 138 | NORTH EUROPEAN OIL ROYALTY TRUST | $225,016 | 0.2% | +0% | 46.9 | |
| 139 | Macy's, Inc. | $224,479 | 0.2% | -63% | 63.6 | |
| 140 | JOHNSON OUTDOORS INC | $224,169 | 0.2% | NEW | 50.7 | |
| 141 | Silence Therapeutics plc | $223,992 | 0.2% | NEW | — | |
| 142 | LB PHARMACEUTICALS INC | $222,868 | 0.2% | NEW | — | |
| 143 | Cogent Biosciences, Inc. | $220,784 | 0.2% | +7% | — | |
| 144 | PHOTRONICS INC | $220,391 | 0.2% | NEW | 56.5 | |
| 145 | FIGS, Inc. | $219,771 | 0.2% | -11% | 64.2 | |
| 146 | Adicet Bio, Inc. | $217,728 | 0.2% | NEW | — | |
| 147 | BICYCLE THERAPEUTICS PLC | $216,664 | 0.2% | NEW | — | |
| 148 | MYRIAD GENETICS INC | $214,125 | 0.2% | NEW | 24.4 | |
| 149 | SUTRO BIOPHARMA, INC. | $212,480 | 0.2% | NEW | 15.3 | |
| 150 | PALISADE BIO, INC. | $208,289 | 0.2% | NEW | — |
New Positions (97)
Exited Positions (66)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Verdad Advisers, LP including:
Track Verdad Advisers, LP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Verdad Advisers, LP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Verdad Advisers, LP
13F Pro is an AI hedge fund tracker and stock research platform. For Verdad Advisers, LP (SEC CIK: 1812822), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Verdad Advisers, LP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.